|Year : 2016 | Volume
| Issue : 1 | Page : 129
Vaccination in Hajj: An overview of the recent findings
Seyed Mansour Razavi1, Mina Saeednejad2, Payman Salamati Prof. 3
1 Department of Community Medicine, Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran
2 Faculty of Medicine, Islamic Azad University, Tehran Medical Branch, Tehran, Iran
3 Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
|Date of Submission||03-Mar-2016|
|Date of Acceptance||16-Nov-2016|
|Date of Web Publication||15-Dec-2016|
Sina Trauma and Surgery Research Center, Sina Hospital, Hassan Abad Square, Imam Khomeini Avenue, Tehran
Source of Support: None, Conflict of Interest: None
Background: About two million people annually travel to Kingdom of Saudi Arabia to perform Hajj. The pilgrims may be at risk of exposure to communicable diseases in this mass gathering and their vaccination against contagious diseases can prevent many morbidities and mortalities. The aim of our study was to review the papers which evaluated effectiveness and compliance of the vaccines applied in Hajj.
Methods: We used PubMed and Scopus to search international medical databases. The key words were as follows: Hajj, Haj, vaccine, vaccination, and immunization. The time interval of the search was from the beginning of 2010 to May 23, 2016. One hundred and thirty papers were extracted, and their contents were subsequently reviewed after title and abstract screenings. The original articles were included in the study and non-English articles were excluded from the study.
Results: Considering the extracted papers, almost all pilgrims were vaccinated against meningococcal diseases. Using of influenza and pneumococcal vaccine rates were different among the pilgrims. The other vaccines have been taking according to specific conditions.
Conclusions: The findings regarding influenza vaccine effectiveness are contradictory. A few studies confirmed the flu vaccine effectiveness while some others rejected its usefulness. Meningococcal immunization is an effective preventive tool with high compliance for Hajj pilgrims. Further investigations are recommended for the other vaccines.
Keywords: Communicable diseases, preventive medicine, travel medicine, vaccination
|How to cite this article:|
Razavi SM, Saeednejad M, Salamati P. Vaccination in Hajj: An overview of the recent findings. Int J Prev Med 2016;7:129
| Introduction|| |
About two million people annually travel to Kingdom of Saudi Arabia (KSA) to perform Hajj. , The pilgrims are exposed to various infectious agents in this mass gathering. Considering previous research, the prevalent infectious disorders among the pilgrims are respiratory, gastrointestinal, and liver diseases.
Common infectious respiratory diseases are the common cold, influenza, exudative pharyngitis, bronchitis, sinobronchitis, sinusitis, pneumonia (viral, classic, and atypical bacteria and mycobacterial), and superimposed infections on asthma. , The common infectious gastrointestinal and liver diseases are gastroenteritis, food poisoning, and hepatitis. 
Furthermore, the responsible infectious pathogens are reported as follows:
Rhinoviruses, ,, coronaviruses (E229 - SARS - MERS),  adenoviruses, both seasonal and pandemic influenza  including, influenza A (H3N2) and B,  influenza H1N1, parainfluenza viruses, respiratory syncytial viruses, herpes simplex virus, ,, meningococcal diseases  and meningococcal carrier state,  emerging hypervirulent strains, i.e., Streptococcus spp.,  Haemophilus influenzae,  Bordetella pertussis,  Chlamydophila pneumoniae, Legionella pneumophila, Mycoplasma pneumonia,  and respiratory tuberculosis. 
Gastrointestinal and liver pathogens
Food poisoning agents,  Vibrio cholerae,  Hepatitis A, E, B, and C. 
The other pathogens
Brucella ,  arboviruses,  phlebovirus (the cause of rift valley fever),  hemorrhagic viruses (Ebola),  and Enterobacillus [Table 1].
Based on the above findings, the greatest risk of infections is related to respiratory and gastrointestinal systems, and some effective vaccines against infections of these two systems are available now.
There are different ideas among Hajj researchers about which vaccines should administer to Hajj pilgrims before their departure to KSA. Hence, the aim of our study was to review the papers which evaluated effectiveness and compliance of the vaccines applied in the Hajj published through the recent years.
| Methods|| |
We used PubMed and Scopus to search international medical databases. The keywords were as follows: Hajj, Haj, vaccine, vaccination, and immunization. The time interval of the search was from the beginning of 2010 to May 23, 2016. The main reason for choosing this period was reviewing only new findings. After removing duplicated records, one hundred and thirty papers were selected, and their contents were subsequently reviewed through title and abstract screenings. The flow diagram of our search steps was presented in [Figure 1]. All original articles which had evaluated effectiveness or compliance of the vaccines administered in the Hajj were included in the study and non-English articles were excluded from the study. Considering our objectives to discuss the common vaccines which administered to pilgrims and since there is other under review vaccines which most Hajj researchers do not agree with their usages, we excluded the papers of the vaccines which were evaluated only in one paper. Two review authors extracted data independently from each study regarding authors, type of vaccine, published year, journal, type of study, location of study, pilgrims' nationality, and a number of participants [Table 2] and [Table 3]. In the next step, the highlighted points were synthesized according to the objectives of our research. No further assessment was performed regarding the quality of the reviewed manuscripts, and the credit of journals was considered sufficient.
|Table 2: The characteristics of the papers which evaluated the vaccine effectiveness in Hajj |
Click here to view
|Table 3: The characteristics of the papers which evaluated the vaccine compliance in Hajj |
Click here to view
| Results|| |
Eleven articles on pneumococcal, meningococcal, and influenza vaccines met our criteria. The studies investigated the effectiveness or compliance of different vaccines in the Hajj. Two papers explained both topics.
Hasan et al. compared the influenza vaccine effectiveness between two groups of vaccinated and nonvaccinated Malaysian Hajj pilgrims. They scored the number of symptoms from 1 to 5. The average score was 0.95 (standard deviation [SD] = 0.9) in the intervention group and 0.88 (SD = 0.69) in the control group (P = 0.781).  In another study, Emamian et al. assessed the effects of influenza vaccination on respiratory tract infections excluding the common cold. Twenty-four patients (75%) in the case group and 48 participants (76.2%) in the control group were vaccinated (P = 0.898).  Moreover, Deris et al. assessed the effectiveness of the influenza vaccine on acute respiratory symptoms of Malaysian pilgrims but found no effect of the vaccine on respiratory symptoms.  Furthermore, Memish et al. studied pilgrims from different countries based on their history of pandemic influenza A vaccination and respiratory infections. The frequency of respiratory infections was higher among people who did not vaccinate compared to those who vaccinated (P = 0.009) [Table 2]. 
Barasheed et al. estimated the influenza vaccination rate among Australian pilgrims in 2 consecutive years. In 2011, of 431 Australians participated in the survey, 65% mentioned receiving the influenza vaccine. In 2012, of 535 Australians, 89% declared receiving the vaccine. 
In another Malaysian study, Deris et al. calculated the influenza vaccine uptake among Malaysian pilgrims. They found that 72.8% of the pilgrims received influenza vaccine before traveling.  As well as, Alqahtani et al. in one study carried out on 356 Australian Hajj pilgrims have shown that vaccination rate against influenza before traveling was 80%. 
Memish et al. also investigated the H1N1 vaccine compliance among 519 arriving and 2699 departing pilgrims. Thirty percent of the pilgrims reported that they had vaccinated against pandemic influenza A before departure to the KSA [Table 3]. 
Memish et al. conducted another study to analyze invasive meningococcal disease (IMD) surveillance data in KSA from 1995 to 2011. They compared the related data before and after the new policy about using polysaccharide quadrivalent ACWY vaccine for pilgrims. They evaluated the changes between the preepidemic and postepidemic periods. The results showed that the mean annual IMD rate decreased from 0.20 (SD) = 0.1-0.06 (SD = 0.06) cases/100,000 (P = 0.02). Moreover, the mean number of Hajj-related diseases changed from 13 (SD = 9.3) to 2 (SD = 2.3) cases/year (P = 0.02). 
Ceyhan et al. performed a study on Turkish Hajjis to assess acquisition of meningococcal carriage in pilgrims who had received polysaccharide quadrivalent ACWY vaccine before their departure to the KSA. They showed that 13% of the 472 participants were meningococcal carriers before Hajj and 27% were meningococcal carriers after Hajj. All of the pilgrims were infected by serogroup W135 [Table 2]. 
Memish et al. evaluated the pilgrim's immunological profile at the time of their entrance to the KSA. Serum samples of 796 out of 861 pilgrims were collected. A total of 98.2% of the pilgrims were vaccinated by the meningococcal quadrivalent in the last 3 years [Table 3]. 
Tashani et al. assessed a group of Australian pilgrims over 3 consecutive years with the aim of the evaluation of the pneumococcal vaccine uptake. The frequencies were as follows: 28.5% (2011), 28.7% (2012), and 14.2% (2013), respectively. 
In addition, Memish et al. evaluated nasopharyngeal samples of 5235 pilgrims from different countries. Only 4.2% of the pilgrims were vaccinated against pneumococcal diseases [Table 3]. 
| Discussion|| |
An important question is whether vaccination against influenza prevents respiratory infections. The findings in various studies are confirmed,  and the efficacy of this vaccine in the prevention of respiratory diseases in the Hajj is not confirmed in some other studies. 
Alqahtani et al. reported that the uptake of seasonal influenza vaccine in different studies ranged from 0.7% to 100% with the highest coverage rate in the elderly pilgrims and those with preexisting comorbidities.  In a study by Razavi et al. on 32,370 Iranian pilgrims, a total of 3465 pilgrims (10.7%) were vaccinated against influenza before departure. The incidence of ILI was about 56% among vaccinated pilgrims against influenza and 72% among those not vaccinated (P < 0.001), with odds ratio = 0.50; thus, the efficacy of the influenza vaccine in this study was 50%. 
Alfelali et al. in one study carried out on 33,213 pilgrims have shown that overall combined data from studies suggest that over the last decade with increasing of influenza vaccination, the influenza-like illness frequency decreased among Hajj pilgrims (RR = 0.2, P < 0.01). 
Ziyaeyan et al.  in one study conducted on 305 Iranian pilgrims have shown some cases of H1N1 pdm09 among the pilgrims after returning to their original country. Most of the cases had the history of vaccination against seasonal influenza.
The effectiveness of the meningococcal vaccine is satisfactory now. Hence, the Ministry of Health of the KSA has considered it as one of the components of the mandatory immunization programs for all pilgrims entering the KSA for the Hajj. The pilgrims' compliance is high for meningococcal vaccination.  Surveillance of meningococcal carriage state in Hajj is recommended. 
In another study, Madani et al. conducted a study on 392 health-care workers in the Hajj services and assessed their compliance with the meningococcal, influenza, and hepatitis B vaccination. They showed that the vaccination coverage level against meningococcal, influenza, and hepatitis B was suboptimal, very low, and suboptimal, respectively.  This study confirms our previous idea regarding the compliance of influenza and meningococcal vaccines among Hajj pilgrims.
Likewise, Read et al. showed that the quadrivalent glycoconjugate meningococcal vaccination decreased the pharyngeal meningococcal carrier state among university students in the UK. Therefore, they suggested that it might affect the transmission when widely used. 
Dbaibo et al., in one study, examined a single-dose vaccine of MenACWY-TT (a kind of meningococcal vaccine conjugated to tetanus toxoid) in 400 healthy adult travelers without the history of tetanus and meningococcal appropriate vaccination. After using a single dose of MenACWY-TT in adults 56 years of age and older, they concluded that this combined vaccine was immunogenic. The vaccine response rate was ≥76%. 
There are studies that show that the use of pneumococcal vaccine to prevent pneumococcal diseases, especially in high-risk patients is efficient. , Dabiran et al. suggested that the high-risk groups in Hajj including patients with chronic obstructive pulmonary disease, asthma, chronic bronchitis, emphysema, cardiac diseases, cancers, and those who have been splenectomy should receive pneumovax-23 vaccine. 
Al-Tawfiq et al. have also stated that the pneumococcal vaccine uptake is 5% in Hajj.  According to a report by Ridda, 90% of pneumococcal serotypes will be covered by the 23-valent pneumococcal polysaccharide vaccine. Therefore, we can use the pneumococcal vaccine in the Hajj, at least for high-risk groups.  On the basis of Alqahtani et al. study, the rate of pneumococcal vaccines uptake was low. 
This author, in another study, has stated that the rate of pneumococcal vaccination among Australian Hajj Pilgrims was 30%.  The Saudi Thoracic Society recommended that all children smaller than 5 years old, people elder than 50 years old, and adults who have specific risk factors and are elder than 6 years old should be vaccinated against pneumococcal infections. 
We presented a summary table of the vaccines which are currently mandatory or recommended by the Saudi authorities in [Table 4].
|Table 4: The vaccines which are currently mandatory or recommended based on the countries (released by the Ministry of Health of Kingdom of Saudi Arabia) |
Click here to view
Tetanus, diphtheria, and pertussis vaccine
Gautret et al., in a cross-sectional survey study which was conducted on 580 pilgrims, reported that the total vaccination rates for tetanus, diphtheria, and poliomyelitis (TdP) were 18.9%, 14.7%, and 15.0%, respectively, which is not an appropriate status. 
Furthermore, in another study, Gautret and Wilder-Smith recommended using a booster dose of tetanus and diphtheria vaccine for travelers.  On the basis of Alqahtani et al. study, the rate of diphtheria vaccines uptake was low.  This author, in another study, has stated that the rate of pertussis vaccine use among Australian Hajj Pilgrims was 30%. 
In addition, Wilder-Smith et al. performed a prospective seroepidemiological study on 358 adult pilgrims and reported that 1.4% of the pilgrims acquired pertussis. Moreover, they recommended that acellular pertussis vaccine should be administered for the pilgrims before the Hajj. 
As poliomyelitis currently occurs in a few countries, the travelers of such countries should be vaccinated against it. 
Tetanus, diphtheria, and poliomyelitis vaccine
Gautret et al., in one cross-sectional study conducted on 580 pilgrims, evaluated social determinants of the Tdp vaccination coverage. They concluded that pilgrims with lower socioeconomic status and linguistic, cultural, and religious characteristics had a low level vaccination against TdP. Inequities of national preventive services were pointed by the authors. 
Yellow fever, typhoid, cholera, and rabies vaccines
In a prospective study, Pavli et al. assessed pretravel vaccination in a total of 2494 travelers in Greece. In this study, 615 (24.7%), 28 (1.1%), 12 (0.5%), 1629 (65.3%), and 666 (26.7%) travelers were vaccinated for typhoid fever, cholera, rabies, yellow fever, and meningococcal infections, respectively. The study showed the necessity of revising the recommendations for people who travel to developing countries. 
Gautret et al., in a cohort study conducted on 461 Hajj pilgrims to Mecca, reported that the rate of vaccination was low and 87% of travelers did not have an appropriate vaccination for pertussis and hepatitis A, 75% for diphtheria and poliomyelitis, 70% for tetanus, and 67% for influenza. 
Currently, polio has been eradicated in most countries except Pakistan, Afghanistan, and Nigeria.  Therefore, to participate in the Hajj rituals, polio vaccination against poliomyelitis is also recommended. 
Shaving the hair by the male pilgrims, Estehlagh, is one of the rituals in the Hajj. In this situation, the pilgrims will shave their hair. This practice is a mental training for forsaking the interests that may drive a man away from spirituality.
During shaving the hair with contaminated blades, the pilgrims may be exposed to some diseases such as hepatitis. Therefore, shaving hygiene and vaccination against diseases such as hepatitis should also be considered.
In an endemic area for rabies where the people are attacked by suspicious animals, they must be vaccinated against the disease on days 0, 3, 7, 14, and 28. 
In this situation, vaccination should be continued during the journey. Therefore, health managers should be prepared to manage these cases, and the principles should not be forgotten.
Moreover, Al-Tawfiq et al. strongly recommended vaccination against yellow fever and poliomyelitis for the pilgrims of high-risk countries and against meningococcal infections for all pilgrims. 
| Conclusions|| |
Meningococcal immunization is an effective preventive tool with high compliance among pilgrims. The findings regarding influenza vaccine effectiveness are contradictory. Hence, further investigations are recommended through original research particularly large cohorts in different populations.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Benkouiten S, Charrel R, Belhouchat K, Drali T, Nougairede A, Salez N, et al.
Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis 2014;20:1821-7.
Benkouiten S, Charrel R, Belhouchat K, Drali T, Salez N, Nougairede A, et al.
Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clin Infect Dis 2013;57:992-1000.
Razavi SM, Mohazzab Torabi S, Salamati P. Treatment and prevention of acute respiratory infections among Iranian hajj pilgrims: A 5-year follow up study and review of the literature. Med J Islam Repub Iran 2014;28:31.
Razavi SM, Sabouri-Kashani A, Ziaee-Ardakani H, Tabatabaei A, Karbakhsh M, Sadeghipour H, et al.
Trend of diseases among Iranian pilgrims during five consecutive years based on a syndromic surveillance system in Hajj. Med J Islam Repub Iran 2013;27:179-85.
Alborzi A, Aelami MH, Ziyaeyan M, Jamalidoust M, Moeini M, Pourabbas B, et al.
Viral etiology of acute respiratory infections among Iranian Hajj pilgrims, 2006. J Travel Med 2009;16:239-42.
Al-Tawfiq JA, Zumla A, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis 2014;12:422-8.
Moattari A, Emami A, Moghadami M, Honarvar B. Influenza viral infections among the Iranian Hajj pilgrims returning to Shiraz, Fars Province, Iran. Influenza Other Respir Viruses 2012;6:e77-9.
Balkhy HH, Memish ZA, Bafaqeer S, Almuneef MA. Influenza a common viral infection among Hajj pilgrims: Time for routine surveillance and vaccination. J Travel Med 2004;11:82-6.
Ashshi A, Azhar E, Johargy A, Asghar A, Momenah A, Turkestani A, et al.
Demographic distribution and transmission potential of influenza A and 2009 pandemic influenza A H1N1 in pilgrims. J Infect Dev Ctries 2014;8:1169-75.
Yezli S, Assiri AM, Alhakeem RF, Turkistani AM, Alotaibi B. Meningococcal disease during the Hajj and Umrah mass gatherings. Int J Infect Dis 2016;47:60-4.
Karsany MS, Elshayeb AA, Saeed ES, Elaagib R, Ibrahim SA, Elsamani E, et al.
Patterns of meningococcal infection in Sudan with emergence of Neisseria meningitidis
serogroup W135. East Mediterr Health J 2013;19:843-6.
Wilder-Smith A, Earnest A, Ravindran S, Paton NI. High incidence of pertussis among Hajj pilgrims. Clin Infect Dis 2003;37:1270-2.
Wilder-Smith A, Foo W, Earnest A, Paton NI. High risk of Mycobacterium tuberculosis
infection during the Hajj pilgrimage. Trop Med Int Health 2005;10:336-9.
Al-Mazrou YY. Food poisoning in Saudi Arabia. Potential for prevention? Saudi Med J 2004;25:11-4.
Gautret P, Benkouiten S, Sridhar S, Al-Tawfiq JA, Memish ZA. Diarrhea at the Hajj and Umrah. Travel Med Infect Dis 2015;13:159-66.
Rafiq SM, Rashid H, Haworth E, Booy R. Hazards of hepatitis at the Hajj. Travel Med Infect Dis 2009;7:239-46.
Memish Z. Brucellosis control in Saudi Arabia: Prospects and challenges. J Chemother 2001;13 Suppl 1:11-7.
Fagbo SF. The evolving transmission pattern of Rift Valley fever in the Arabian Peninsula. Ann N Y Acad Sci 2002;969:201-4.
Al-Tawfiq JA, Memish ZA. The Hajj: Updated health hazards and current recommendations for 2012. Euro Surveill 2012;17:20295.
Hasan H, Deris ZZ, Sulaiman SA, Abdul Wahab MS, Naing NN, Ab Rahman Z, et al.
Effect of influenza vaccination on acute respiratory symptoms in Malaysian Hajj pilgrims. J Immigr Minor Health 2015;17:1114-9.
Emamian MH, Hassani AM, Fateh M. Respiratory tract infections and its preventive measures among Hajj pilgrims, 2010: A nested case control study. Int J Prev Med 2013;4:1030-5.
Deris ZZ, Hasan H, Sulaiman SA, Wahab MS, Naing NN, Othman NH. The prevalence of acute respiratory symptoms and role of protective measures among Malaysian Hajj pilgrims. J Travel Med 2010;17:82-8.
Memish ZA, Assiri AM, Hussain R, Alomar I, Stephens G. Detection of respiratory viruses among pilgrims in Saudi Arabia during the time of a declared influenza A (H1N1) pandemic. J Travel Med 2012;19:15-21.
Memish Z, Al Hakeem R, Al Neel O, Danis K, Jasir A, Eibach D. Laboratory-confirmed invasive meningococcal disease: Effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011. Euro Surveill 2013;18. pii: 20581.
Ceyhan M, Celik M, Demir ET, Gurbuz V, Aycan AE, Unal S. Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine. Clin Vaccine Immunol 2013;20:66-8.
Memish ZA, Yezli S, Almasri M, Assiri A, Turkestani A, Findlow H, et al.
Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims. Int J Infect Dis 2014;28:171-5.
Memish ZA, Assiri A, Almasri M, Alhakeem RF, Turkestani A, Al Rabeeah AA, et al.
Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis 2014;210:1067-72.
Barasheed O, Rashid H, Heron L, Ridda I, Haworth E, Nguyen-Van-Tam J, et al.
Influenza vaccination among Australian Hajj pilgrims: Uptake, attitudes, and barriers. J Travel Med 2014;21:384-90.
Alqahtani AS, Wiley KE, Tashani M, Willaby HW, Heywood AE, BinDhim NF, et al.
Exploring barriers to and facilitators of preventive measures against infectious diseases among Australian Hajj pilgrims: Cross-sectional studies before and after Hajj. Int J Infect Dis 2016;47:53-9.
Tashani M, Barasheed O, Azeem M, Alfelali M, Badahdah AM, Bokhary H, et al.
Pneumococcal vaccine uptake among Australian Hajj pilgrims in 2011-2013. Infect Disord Drug Targets 2014;14:117-24.
Razavi SM, Sadegi-Hasanabadi M, Salamati P. The comparison of influenza vaccine efficacy on respiratory disease among Iranian pilgrims. Acta Med Iran 2005;43:279-81.
Razavi SM, Dabiran S, Ardekani HZ. The incidence of influenza like illness and determination of the efficacy of flu vaccine in Iranian pilgrims during Hajj pilgrimage. Acta Med Iran 2004;42:397-401.
Alfelali M, Barasheed O, Tashani M, Azeem MI, El Bashir H, Memish ZA, et al.
Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: A 10-year retrospective analysis of data. Vaccine 2015;33:2562-9.
Ziyaeyan M, Alborzi A, Jamalidoust M, Moeini M, Pouladfar GR, Pourabbas B, et al.
Pandemic 2009 influenza A (H1N1) infection among 2009 Hajj pilgrims from Southern Iran: A real-time RT-PCR-based study. Influenza Other Respir Viruses 2012;6:e80-4.
Madani TA, Ghabrah TM. Meningococcal, influenza virus, and hepatitis B virus vaccination coverage level among health care workers in Hajj. BMC Infect Dis 2007;7:80.
Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, et al.
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial. Lancet 2014;384:2123-31.
Dbaibo G, El-Ayoubi N, Ghanem S, Hajar F, Bianco V, Miller JM, et al.
Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 years and older: Results of an open-label, randomized, controlled trial. Drugs Aging 2013;30:309-19.
Dabiran S, Razavi SM, Sabouri-Kashani A, Karbakhsh M, Naser-Hodjati H, Peyafarin F. Effects of flu vaccine, solely or accompanied by pneumovax-23 vaccine on clinical consequences of the respiratory diseases among Iranian pilgrims in Hajj. Health 2014;6:1-5.
Alharbi NS, Al-Barrak AM, Al-Moamary MS, Zeitouni MO, Idrees MM, Al-Ghobain MO, et al.
The Saudi Thoracic Society pneumococcal vaccination guidelines-2016. Ann Thorac Med 2016;11:93-102.
Al-Tawfiq JA, Memish ZA. Prevention of pneumococcal infections during mass gathering. Hum Vaccin Immunother 2016;12:326-30.
Ridda I, King C, Rashid H. Pneumococcal infections at Hajj: Current knowledge gaps. Infect Disord Drug Targets 2014;14:177-84.
Alqahtani AS, Rashid H, Heywood AE. Vaccinations against respiratory tract infections at Hajj. Clin Microbiol Infect 2015;21:115-27.
Gautret P, Yong W, Soula G, Parola P, Brouqui P, DelVecchio Good MJ. Determinants of tetanus, diphtheria and poliomyelitis vaccinations among Hajj pilgrims, Marseille, France. Eur J Public Health 2010;20:438-42.
Gautret P, Wilder-Smith A. Vaccination against tetanus, diphtheria, pertussis and poliomyelitis in adult travellers. Travel Med Infect Dis 2010;8:155-60.
Pavli A, Spilioti A, Lymperi I, Katerelos P, Maltezou HC. Vaccinations for international travellers travelling from Greece. Travel Med Infect Dis 2013;11:225-30.
Gautret P, Gaillard C, Soula G, Delmont J, Brouqui P, Parola P. Pilgrims from Marseille, France, to Mecca: Demographics and vaccination status. J Travel Med 2007;14:132-3.
Ahmed QA, Nishtar S, Memish ZA. Poliomyelitis in Pakistan: Time for the Muslim world to step in. Lancet 2013;381:1521-3.
Wilder-Smith A, Leong WY, Lopez LF, Amaku M, Quam M, Khan K, et al.
Potential for international spread of wild poliovirus via travelers. BMC Med 2015;13:133.
Rupprecht CE. Viral zoonoses - Rabies. In: Wallace RB, Kohatsu N, editors. Maxey-Rosenau-Last Public Health and Preventive Medicine. 15 th
ed. New York: McGraw-Hill; 2008. p. 419-23.
[Table 1], [Table 2], [Table 3], [Table 4]